Prolx Pharmaceuticals Inc Pittsburgh, PA - 15219

Prolx Pharmaceuticals Inc is categorized under Noncommercial Research Organizations in Pittsburgh, PA and active since 2011.

Prolx Pharmaceuticals Inc was established in 2011, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Noncommercial Research Organizations business, which does work in the B2B market, and is classified as a Noncommercial Research Organizations, under code number 4461100 by the NAICS.

If you are seeking more information, feel free to contact Lynn Kirkpatrick at the company’s single location by writing to 1401 Forbes Avenue, Pittsburgh, Pennsylvania PA 15219 or by phoning (412) 201-2477. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Prolx Pharmaceuticals Inc
Contact Person: Lynn Kirkpatrick
Address: 1401 Forbes Avenue, Pittsburgh, Pennsylvania 15219
Phone Number: (412) 201-2477
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2011
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Noncommercial Research Organizations
SIC Code: 8733
NAICS Code: 4461100
Share This Business:

Prolx Pharmaceuticals Inc was started in 2011 to provide professional Noncommercial Research Organizations under the SIC code 8733 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Lynn Kirkpatrick for inquiries that concern Prolx Pharmaceuticals Inc by calling the company number (412) 201-2477, as your correspondence is most welcome. Additionally, the physical location of the single location of Prolx Pharmaceuticals Inc can be found at the coordinates 40.43775,-79.98606 as well as the street address 1401 Forbes Avenue in Pittsburgh, Pennsylvania 15219.

For its online presence, you may visit Prolx Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.